Indomethacin eyedrops and the postoperative irritation after extracapsular cataract extraction combined with intraocular lens implantation

Doc Ophthalmol. 1983 Dec 15;56(1-2):165-70. doi: 10.1007/BF00154725.

Abstract

Indomethacin 0.5% solution eyedrops inhibit the prostaglandin effects after extracapsular cataract extraction combined with intraocular lens implantation. In a double-blind study Indomethacin was compared to Dexamethason and placebo using corneal thickness and iris vessel dilatation and leakage as parameters for postoperative irritation. The present evidence indicates that Indomethacin is an important additive medication to diminish the postoperative reaction.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Cornea
  • Humans
  • Indomethacin / therapeutic use*
  • Lenses, Intraocular*
  • Ophthalmic Solutions
  • Postoperative Complications / prevention & control
  • Premedication

Substances

  • Ophthalmic Solutions
  • Indomethacin